Bayer, Regeneron get EU nod for Eylea's label extension

1 week ago 1

• Healthcare

Sharamand/iStock via Getty Images

• Bayer A.G. (OTCPK:BAYZF) (OTCPK:BAYRY) said on Friday that the European Commission has approved a label extension for Eylea 8 mg.
• The label extension allows treatment intervals of up to 6 months for wet age-related macular degeneration and visual impairment caused

Recommended For You

More Trending News

See More »

1. Homepage
2. Politics
3. Bayer, Regeneron get EU nod for Eylea's label extension